Summary Dynatrace recently reported strong results for Q1 operations. Despite the impact of the virus on the economy it was able to show growth reacceleration-a rare achievement indeed for this time. The company, in its presentation, projected lots of tailwinds and a deepening competitive moat based on some specific bits of functionality. Despite all of…
As foreshadowed in a previous post, we are making a change in our high growth portfolio. We are selling Avalara and buying Dynatrace. We had 230 shares of Avalara which we sold on close this afternoon at $97.62/share. That raised $22,450. We bought 700 shares of Dynatrace at $32/share which cost $22,400. We added the…
Fastly (FSLY) Speeds Up; Avalara’s valuation starts to exceed its relative value. Last week was the apogee of earnings season, although there will be a few names of interest reporting this week. We continue to comment on names in our high-growth portfolio that have reported. As we clear the backlog of comments, we will catch…
The market continues to climb that proverbial wall of worry. After a rather difficult May 1st markets continue to rally. From time to time I read commentators bemoaning this supposedly “unloved” rally. Yesterday I spoke to a subscriber who has chosen to escape the rally, hiding out in cash. His issue is how does anyone forecast…
Summary Alteryx reported its results last week. Revenues were a beat, EPS was not. The company provided exceptionally prudent guidance for. Q2 and withdrew guidance for the balance of the year. This is the leading company in one of the fastest growing software spaces. It has material competitive advantages and it continues to grow it…
As of the opening this morning, we are making a change in our portfolio. We are selling 35 shares of TTD at a price of $307. This sale nets us $10,750. We are buying a similar amount of Rapid 7. Our entry price is $46.97, and we have bought 228 shares that cost $20,731. We…
Nutanix announced some preliminary revenue results for its 3rd fiscal quarter that ended on April 30th. The results were better than had been feared, particularly in light of the fact that the company has begun a furlough program to reduce operating expenses. Not terribly surprisingly, and consistent with actions of many other vendors, the company withdrew…
It was announced this afternoon in some of the trade press that Nutanix has furloughed some of its staff. The specifics of the announcement are that about 25% of the staff at Nutanix will have two week-long furloughs between May 4th and October 31st. The company talked about taking “deliberate and proactive expense-reduction measures that we…
Prosperity in the time of the Virus Although the impact of the virus on the economy is pervasive, the fact is that some companies, depending on their product set, and sales execution have shown more resilience than others. These are not “virus” stocks. There is no positive correlation between demand for their products and the…
This week and next week are a seasonal peak in earnings reports for the quarter ending 3/31. I don’t expect to write on every single name in the next few days, but will try to concentrate on those that are interesting or are in one of our two model portfolios. The most interesting story so…